NovoCure Ltd. (NVCR)
11.36
-0.03
(-0.26%)
USD |
NASDAQ |
Feb 20, 16:00
11.33
-0.03
(-0.26%)
After-Hours: 20:00
NovoCure SG&A Expense (Quarterly) : 104.47M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| LivaNova Plc | 138.52M |
| AtriCure, Inc. | 78.34M |
| Abbott Laboratories | 3.129B |
| Accuray, Inc. | 18.91M |
| Plus Therapeutics, Inc. | 3.443M |